Phenominer Database Results (7 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Record ID Study ID
LOU/M post-insult time to onset of experimental autoimmune encephalomyelitis Freund's complete adjuvant (0.05-0.1 ml) and human myelin basic protein (0.05-0.1 ml) then pertussis toxin (3.5 ug) then pertussis toxin (3.5 ug) Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. central nervous system integrity trait not specified 95 days-114 days 5 11.0 d 0.0 0.0 in vivo visual assessment 2592000.0 0 110796 3186
LOU/M experimental autoimmune encephalomyelitis duration Freund's complete adjuvant (0.05-0.1 ml) and human myelin basic protein (0.05-0.1 ml) and cyclophosphamide (8 mg) then cyclophosphamide (5 mg) Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. central nervous system integrity trait not specified 95 days-114 days 4 11.0 d 0.0 0.0 in vivo visual assessment 2592000.0 0 110801 3186
LOU/M percentage of study population developing experimental autoimmune encephalomyelitis during a period of time Freund's complete adjuvant (0.05-0.1 ml) and human myelin basic protein (0.05-0.1 ml) and cyclophosphamide (5 mg) then cyclophosphamide (8 mg) Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. central nervous system integrity trait not specified 95 days-114 days 4 100.0 % 0.0 0.0 in vivo visual assessment 2592000.0 0 110793 3186
LOU/M percentage of study population developing experimental autoimmune encephalomyelitis during a period of time Freund's complete adjuvant (0.05-0.1 ml) and human myelin basic protein (0.05-0.1 ml) then pertussis toxin (3.5 ug) then pertussis toxin (3.5 ug) Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. central nervous system integrity trait not specified 95 days-114 days 5 100.0 % 0.0 0.0 in vivo visual assessment 2592000.0 0 110792 3186
LOU/M post-insult time to onset of experimental autoimmune encephalomyelitis Freund's complete adjuvant (0.05-0.1 ml) and human myelin basic protein (0.05-0.1 ml) and cyclophosphamide (8 mg) then cyclophosphamide (5 mg) Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. central nervous system integrity trait not specified 95 days-114 days 4 11.0 d 0.0 0.0 in vivo visual assessment 2592000.0 0 110797 3186
LOU/M percentage of study population developing experimental autoimmune encephalomyelitis during a period of time Freund's complete adjuvant (0.05-0.1 ml) and human myelin basic protein (0.05-0.1 ml) Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. central nervous system integrity trait not specified 95 days-114 days 4 0.0 % 0.0 0.0 in vivo visual assessment 2592000.0 0 110790 3186
LOU/M experimental autoimmune encephalomyelitis duration Freund's complete adjuvant (0.05-0.1 ml) and human myelin basic protein (0.05-0.1 ml) then pertussis toxin (3.5 ug) then pertussis toxin (3.5 ug) Hashim G, etal., J Immunol. 1991 Jan 15;146(2):515-20. central nervous system integrity trait not specified 95 days-114 days 5 8.0 d 0.0 0.0 in vivo visual assessment 2592000.0 0 110800 3186